A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Each analysis uses advanced methods such as HPLC and mass spectrometry, guaranteeing the highest research quality
They went back, and they got in touch with 15 of their past customers, and they asked them if the injections had helped
Here is the vendor: Limitless Life Limitless Life is the best source of high-quality research peptides for several reasons including their stringent quality protocols, commitment to safety and responsible peptide distribution, trustworthiness and reputation, and outstanding customer service
That said, its worth noting that the evidence supporting these uses is still limited, and more research is needed
10.7554/eLife.02872 75 NardelliF.GhittiM.QuiliciG.GoriA.LuoQ.BerardiA.et al (2019)
